Casdin Capital, LLC Codexis, Inc. Transaction History
Casdin Capital, LLC
- $855 Million
- Q1 2025
A detailed history of Casdin Capital, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 8,100,000 shares of CDXS stock, worth $19.4 Million. This represents 2.55% of its overall portfolio holdings.
Number of Shares
8,100,000
Previous 8,100,000
-0.0%
Holding current value
$19.4 Million
Previous $38.6 Million
43.61%
% of portfolio
2.55%
Previous 3.32%
Shares
14 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
63.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$22.8 Million7.03% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$16.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$11.3 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$7.2 Million1.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.83MShares$6.79 Million0.34% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $157M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...